Group
MEK inhibitor
The data below refer to patients treated with MEK inhibitor as the sole drug class,
excluding any concurrent use of drugs from other groups.
Combination therapy data are available in the section below.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Binimetinib
No data
Cobimetinib
No data
Trametinib
No data